Chinnampalli KV. FROM RISK TO QUALITY: QUALITY RISK MANAGEMENT IN PHARMA TARGETING CANCER THROUGH IMMUNE MODULATION . Biospecia [Internet]. 2026 May 23 [cited 2026 Jul. 29];2(2):13-7. Available from: https://uniquepubinternational.com/journals/index.php/biospecia/article/view/211